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In this, my first issue of ATLA as Editor-in-Chief, I would
like to introduce myself and to share with you my vision for
the evolution of the journal in the months ahead. Since its
inception, ATLA has played a key role in identifying, col-
lating and disseminating the latest ideas and innovations in
the area of alternatives. Truly multidisciplinary in its scope,
ATLA has provided the waymarkers for the journey towards
replacing the use of animals in experiments. In terms of
moving towards replacement, I view this very much as a
journey, from past practice where animal testing was
undertaken with scant consideration of alternatives, to a
future where such testing has been consigned to history,
as science evolves to provide the requisite answers through
the integration of alternative methods, relevant to the spe-
cies of interest, that are fully acceptable to all stakeholders
— industry, consumers and regulators.
“Are we nearly there yet?” You will no doubt recognise
that this is the inevitable question, but how can we gain the
most insightful response to it? In the context of both long
journeys with restless passengers and moving towards
replacement, the question itself is not particularly construc-
tive. One problem is that it invites a simple ‘Yes/No’
response. But would a binary response be appropriate for
this complex situation? I suspect that, if we were very close
to this particular journey’s end, then we would already
know the answer, all systems would be in place for relying
on alternatives and the question would then be redundant. If
the answer were ‘No’, then we have not learned very much
from posing the question.
Two, more pertinent, questions may help to elicit a more
appropriate response: Firstly, “How far away are we?”; and
secondly, “What is the most efficient route forward?” I do
not claim to have the answer to those two questions either!
However, we now have opened up an essential debate,
enabling those interested to express an opinion on how
much further there is to go and what we can do to get there
faster. Through well-informed scientific debate and
exchange of ideas and innovations, we can move forward
more efficiently; this is the raison d’eˆtre for a scientific
journal.
There is an ever-increasing number of journals, testa-
ment to the astounding pace of scientific developments in
our time and the need to make this new information avail-
able to others. However, no one person can be an expert
across multiple disciplines, and science advances so rapidly
that it is impossible to maintain a breadth of knowledge in
numerous diverse subjects. The unfortunate consequence
of this is that scientists may be unaware of ideas, new
practices or innovations in one area that could be used to
advantage across a range of other areas. It is generally
accepted that, for the majority of scenarios, no single alter-
native solution (such as an in vitro assay or an in silico
model) can be used alone as a one-for-one replacement
of existing animal tests. The replacement of animals is
more likely to be achieved through the application of a
wide range of alternative methods, each supplying a piece
of information that can be used to complete the picture.
What we are trying to accomplish through the use of
alternative methods is highly complex. We want to know
how different organisms (environmental species, farm/
companion animals, humans, etc.) will respond to the pres-
ence of a chemical, or mixture of chemicals, to which it is
exposed. The chemical may be a pharmaceutical, food
ingredient, cosmetic or environmental pollutant. The
organism may be exposed at a low level on a daily basis
for many years or exposed to a single high dose on one
occasion. It could be at any stage of its life cycle — newly
developing or aged — it may be healthy, diseased or par-
ticularly susceptible for a number of reasons. How can we
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predict the potential responses, across all relevant species,
for all chemicals of interest under different exposure sce-
narios? In order to solve such enormously complicated
problems, we need to be aware of all of the tools at our
disposal, to understand the potential that each tool has to
offer and look beyond our own area of expertise to embrace
all that is available. A hammer is a very useful tool, but you
cannot build a house with it. To build something complex,
imaginative and forward-looking, you need to appreciate
the full array of existing tools; what they are capable of,
their individual potential and limitations, and how they can
be used in combination to solve more intricate problems.
Importantly, this also helps to identify the gaps in what is
currently achievable with alternative methods and, there-
fore, where future efforts should be directed.
There have been tremendous advances in the comple-
mentary fields of in vitro, in silico and in chemico tech-
niques as well as mathematical biology and -omics. These
can provide a wealth of diverse information that can be
used to inform (quantitative) adverse outcome pathway
((q)AOP) development and systems biology approaches.
Systems biology and qAOPs provide frameworks for a
more mechanistic understanding of how chemicals can
interact with biological macromolecules to elicit an effect;
this fundamental research aids our understanding of activ-
ity, toxicity and internal distribution of chemicals. These
approaches can be used synergistically to fill gaps in
knowledge and build a complete picture of chemical–bio-
logical interactions that in future will obviate the reliance
on animal use in product development and safety assess-
ment across all sectors.
The focus of the Fund for the Replacement of Animals
in Medical Experiments (FRAME) reflects this philosophy:
that new methods for the replacement of animals in experi-
ments must be based upon the principles of best scientific
practice. Therefore, the vision for ATLA (FRAME’s scien-
tific journal) is for it to build upon its strong history as a
resource where the latest innovations, ideas and methods,
based on the Three Rs principles are collated, promoted and
disseminated as widely as possible.
ATLA is a unique journal that brings together the many
facets of the underlying research and how it can be applied.
While broadly encompassing topics such as in vitro testing,
in silico modelling, mathematical biology, -omics, data
mining, and systematic reviews, it is recognised that within
these areas is a multitude of sub-disciplines to be investi-
gated. In the forthcoming issues, a series of special collec-
tions is planned for ATLA, each presenting a state-of-the-art
review of a key subject area, with accompanying articles
exemplifying how the research is applied within academia,
industry and/or the regulatory sector. These reviews will
include the potential uses and limitations of the techniques,
current barriers to uptake, how these may be overcome and
how the area is likely to develop in the next few years.
Unarguably, the most important resource in every disci-
pline is the people involved: researchers, developers, pro-
moters and decision makers. New initiatives planned for
ATLA will also involve supporting the education and fos-
tering the enthusiasm, of those new to the area, reporting
ongoing activities and opportunities for development.
As the overriding purpose is to expedite progress
towards the replacement of animals, it remains essential
that the journal continues to provide scrutiny of the extent
and nature of animal use, the uptake of alternatives (or lack
thereof) across different sectors and the implications of
international legislation from the perspective of animal
welfare. There is still some way to go on the journey to
replacement: I hope that you enjoy the quest and discover
new ideas to capture your interest and imagination along
the way.
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